Scintillon News
Spotlight Series on our Incubator companies: Pomelo Biosciences Inc
October 14, 2025
The Scintillon Research Institute is home to a growing number of young and promising startups within the SI-START incubator/accelerator program. The vision is to support and expand the biotech ecosystem in the greater San Diego area and drive innovation….
This month, as part of our inaugural Spotlight Series, we highlight one of our resident companies, Pomelo Biosciences, Inc. and go behind the scenes to chat with Founder and CEO Dr. Yun C. Yung about his vision for the company.
The Scintillon Research Institute’s 8th Annual SURE Program: Training and Inspiring the Scientists of Tomorrow
October 9, 2025
The summer of 2025 marked the eighth year of the Scintillon Institute’s highly selective SURE (Summer Research) Program. This immersive four-week experience empowers San Diego’s top high school and some college students to work alongside leading biomedical researchers. Designed to ignite curiosity and foster a deep passion for science, SURE provides unmatched hands-on exposure to cutting-edge biomedical research and authentic laboratory environments.
Directly Connecting DNA Epigenetic Player with Mitochondrial Metabolism via RNA Binding
DNA methyltransferase 1 modulates mitochondrial function through bridging m5C RNA methylation
May 22, 2025
In a recent issue of Molecular Cell, Prof. Guoping Fan from Scintillon Institute together with colleagues at UCLA and ShanghaiTech University published an article titled “DNA methyltransferase 1 modulates mitochondrial function through bridging m5C RNA methylation”.
Neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease are often accompanied by energy metabolism disorders and mitochondrial dysfunction. In recent years, the role of epigenetic regulatory mechanisms, especially DNA and RNA methylation, in these diseases has gradually attracted attention.